People with strabismus, myopia, amblyopia, and other common eye conditions are 40% more likely to develop attention-deficit/hyperactivity disorder (ADHD) than those ...

Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and ...

The Ocular Neurobiology laboratory at the Institute for Neurosciences, a joint center of Miguel Hernández University (UMH) in Elche and the Spanish National Research Council (CSIC), is participating ...

For some degenerative vision disorders, the therapies available don’t restore sight, they mainly slow its decline. To realize this benefit, a patient must receive an eye injection as frequently as ...

Researchers at the University of Twente and Radboudumc are developing a promising new model to enhance understanding of the ...

Semaglutide showed no significant association with increased risk of eye disorders or diabetic retinopathy in the meta-analysis. A potential link between semaglutide and increased risk of NAION was ...

According to different studies done globally, about 80 per cent of blindness is avoidable if diagnosed and treated early. Thus, paediatric eye care service plays a vital role in the elimination of ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa. Researchers at the National Institutes of Health (NIH) have developed eye drops ...